ETF Managers Group’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $570K | Buy |
24,797
+370
| +2% | +$8.5K | 0.02% | 413 |
|
|
2022
Q4 | $686K | Buy |
24,427
+890
| +4% | +$25K | 0.03% | 246 |
|
|
2022
Q3 | $666K | Buy |
23,537
+911
| +4% | +$25.8K | 0.02% | 287 |
|
|
2022
Q2 | $506K | Buy |
22,626
+9,168
| +68% | +$205K | 0.01% | 473 |
|
|
2022
Q1 | $395K | Buy |
13,458
+225
| +2% | +$6.6K | 0.01% | 507 |
|
|
2021
Q4 | $444K | Buy |
13,233
+630
| +5% | +$21.1K | 0.01% | 533 |
|
|
2021
Q3 | $582K | Buy |
12,603
+969
| +8% | +$44.7K | 0.01% | 496 |
|
|
2021
Q2 | $623K | Buy |
11,634
+2,579
| +28% | +$138K | 0.01% | 417 |
|
|
2021
Q1 | $446K | Buy |
9,055
+1,218
| +16% | +$60K | 0.01% | 495 |
|
|
2020
Q4 | $349K | Buy |
7,837
+696
| +10% | +$31K | 0.01% | 519 |
|
|
2020
Q3 | $246K | Buy |
7,141
+355
| +5% | +$12.2K | 0.01% | 552 |
|
|
2020
Q2 | $360K | Buy |
6,786
+2,710
| +66% | +$144K | 0.01% | 329 |
|
|
2020
Q1 | $144K | Buy |
4,076
+416
| +11% | +$14.7K | 0.01% | 499 |
|
|
2019
Q4 | $176K | Buy |
3,660
+839
| +30% | +$40.3K | 0.01% | 522 |
|
|
2019
Q3 | $97K | Sell |
2,821
-30
| -1% | -$1.03K | ﹤0.01% | 521 |
|
|
2019
Q2 | $142K | Buy |
2,851
+1,102
| +63% | +$54.9K | ﹤0.01% | 519 |
|
|
2019
Q1 | $118K | Buy |
1,749
+157
| +10% | +$10.6K | 0.01% | 475 |
|
|
2018
Q4 | $73K | Buy |
1,592
+216
| +16% | +$9.91K | ﹤0.01% | 530 |
|
|
2018
Q3 | $106K | Buy |
1,376
+144
| +12% | +$11.1K | ﹤0.01% | 474 |
|
|
2018
Q2 | $642 | Buy |
1,232
+29
| +2% | +$15 | 0.05% | 160 |
|
|
2018
Q1 | $89K | Buy |
1,203
+150
| +14% | +$11.1K | 0.01% | 310 |
|
|
2017
Q4 | $63K | Buy |
1,053
+150
| +17% | +$8.97K | ﹤0.01% | 450 |
|
|
2017
Q3 | $60K | Buy |
903
+82
| +10% | +$5.45K | 0.01% | 253 |
|
|
2017
Q2 | $42K | Buy |
+821
| New | +$42K | ﹤0.01% | 511 |
|
|
2016
Q1 | $33K | Buy |
+567
| New | +$33K | 0.02% | 261 |
|